Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
11/02/2000 | WO2000065053A2 Compositions and methods for therapy and diagnosis of head/neck and lung squamous cell carcinoma |
11/02/2000 | WO2000065052A1 Bridge-1, a transcription factor |
11/02/2000 | WO2000065051A1 Pollinosis-associated gene 627 |
11/02/2000 | WO2000065050A1 Pollinosis-associated gene 795 |
11/02/2000 | WO2000065049A1 Pollinosis-associated gene 513 |
11/02/2000 | WO2000065048A1 Pollinosis-associated gene 581 |
11/02/2000 | WO2000065047A1 Tumor suppressor genes |
11/02/2000 | WO2000065046A1 Pollinosis-associated gene 373 |
11/02/2000 | WO2000065045A1 Pollinosis-associated gene 419 |
11/02/2000 | WO2000065044A1 Apoptosis-associated proteins |
11/02/2000 | WO2000065043A1 Use of a recombinant defective adenovirus comprising a nucleic acid encoding an angiogenic factor for treating pulmonary hypertension |
11/02/2000 | WO2000065042A1 P element derived vector and methods for its use |
11/02/2000 | WO2000065040A2 Cell cycle genes from plants and methods of use |
11/02/2000 | WO2000065039A2 Identification of dna control elements responsive to specific stimuli |
11/02/2000 | WO2000065038A2 Methods, compositions, and cells for encapsidating recombinant vectors in aav particles |
11/02/2000 | WO2000065037A2 Maize npr1 polynucleotides and methods of use |
11/02/2000 | WO2000065034A2 Pseudotyped retroviral vector for gene therapy of cancer |
11/02/2000 | WO2000065032A1 Porcine reproductive and respiratory syndrome vaccine, based on isolate ja-142 |
11/02/2000 | WO2000065028A2 TGF-α POLYPEPTIDES, FUNCTIONAL FRAGMENTS AND METHODS OF USE THEREFOR |
11/02/2000 | WO2000065027A2 Human gil-19/ae289 proteins and polynucleotides encoding same |
11/02/2000 | WO2000065026A2 YycG |
11/02/2000 | WO2000064946A2 Compositions and methods for cancer treatment by selectively inhibiting vegf |
11/02/2000 | WO2000064945A1 Inhibition of endopeptidase by cystatins |
11/02/2000 | WO2000064944A1 Treatment of fibrosis by antagonism of il-13 and il-13 receptor chains |
11/02/2000 | WO2000064943A1 Acrp30r1m, a homolog of acrp30 |
11/02/2000 | WO2000064942A1 Axor-27, a g-protein coupled receptor |
11/02/2000 | WO2000064941A2 G-protein coupled receptor and method of using same |
11/02/2000 | WO2000064940A1 Insulin crystals for pulmonary administration |
11/02/2000 | WO2000064939A2 Peptides derived from vasostatin i and the use thereof as anti-fungal agents |
11/02/2000 | WO2000064938A2 Peptide homodimers or peptide heterodimers derived from interleukin 12 |
11/02/2000 | WO2000064937A1 Inactivated cytokines for immunisation |
11/02/2000 | WO2000064936A2 PEPTIDE HOMODIMERS AND PEPTIDE HETERODIMERS, DERIVED FROM INTERFERON α2 |
11/02/2000 | WO2000064935A1 A novel serotonin-gated anion channel |
11/02/2000 | WO2000064934A1 Therapeutic compositions and methods for treating tumors |
11/02/2000 | WO2000064933A1 Transcriptional activation inhibitory protein |
11/02/2000 | WO2000064932A1 Neuronal exocytosis inhibiting peptides and cosmetic and pharmaceutical compositions containing said peptides |
11/02/2000 | WO2000064931A1 A ligand of the protein 'beacon' |
11/02/2000 | WO2000064930A2 Tribonectins |
11/02/2000 | WO2000064929A1 Membrane disruptive peptides covalently oligomerized |
11/02/2000 | WO2000064928A2 Transmembrane (7tm) receptor r35) |
11/02/2000 | WO2000064925A1 Method of inhibiting leukocyte adhesion to fibrinogen |
11/02/2000 | WO2000064920A1 Compositions, methods, and kits relating to resistin |
11/02/2000 | WO2000064919A1 Compositions, methods, and kits relating to the tig-1 gene, a novel tzd inducible gene |
11/02/2000 | WO2000064489A2 Diagnostic marker for the human heart |
11/02/2000 | WO2000064488A2 Somatic transgene immunization and related methods |
11/02/2000 | WO2000064482A1 Nerve cell growth modulators (amphibodies) |
11/02/2000 | WO2000064479A1 Compositions containing tetracyclines for treating hemorrhagic virus infections and other disorders |
11/02/2000 | WO2000064475A1 Treatment of metastatic cancer through mts-1 gene |
11/02/2000 | WO2000064465A1 Death domain containing receptors |
11/02/2000 | WO2000064457A1 Genetically engineered oral commensal organisms as vaccines |
11/02/2000 | WO2000064261A1 Role of vascular endothelial growth factor-b (vegf-b) in developing bones and uses thereof |
11/02/2000 | WO2000044889A3 Mammal with inducible ductal carcinoma in situ |
11/02/2000 | WO2000044394A8 Method of producing elastin, elastin-based materials and tropoelastin materials |
11/02/2000 | WO2000043514A3 Human acid sensing ion channel and uses thereof |
11/02/2000 | WO2000043509A3 Polynucleotides and their applications in diagnostics |
11/02/2000 | WO2000041516A3 Reagents and methods useful for detecting diseases of the breast |
11/02/2000 | WO2000041508A3 Combination therapy of cancer by the activation of co-stimulatory molecules expressed by immune cells and cytokines |
11/02/2000 | WO2000040723A3 Methods and products for delivering nucleic acids |
11/02/2000 | WO2000039299A3 Streptococcus antigens |
11/02/2000 | WO2000039279A3 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
11/02/2000 | WO2000039136A3 Human brainiac-5 |
11/02/2000 | WO2000037642A9 Method of enhancing the biological activity of ligands |
11/02/2000 | WO2000037640A9 Compositions and methods for the treatment of tumor |
11/02/2000 | WO2000037093A8 Bone resorption inhibitors |
11/02/2000 | WO2000028061A9 Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same |
11/02/2000 | WO2000024876A3 Spumavirus isolated from humans |
11/02/2000 | WO2000024873A9 Process for recovering heterologous polypeptides from bacterial cells |
11/02/2000 | WO2000018932A3 Receptor based antagonists and methods of making and using |
11/02/2000 | WO2000018917A3 α-SYNUCLEIN SUPER-MUTANTS ACCELERATE α-SYNUCLEIN AGGREGATION |
11/02/2000 | WO2000006592A9 Nucleic acids encoding a g-protein coupled receptor involved in sensory transduction |
11/02/2000 | WO2000004926A3 Conjugates for treating inflammatory disorders and associated tissue damage |
11/02/2000 | WO1998042851A8 Plants with modified growth |
11/02/2000 | EP1048736A1 DNA-construct for the tissue specific expression of a blood coagulation factor |
11/02/2000 | EP1048735A1 DNA-construct for the tissue-specific expression of a blood coagulation factor |
11/02/2000 | EP1048734A2 Compositions containing plant-produced glycopolypeptide multimers, multimeric proteins, and their use |
11/02/2000 | EP1048733A2 Plant promoters |
11/02/2000 | EP1048732A1 Process for producing natural folded and secreted proteins |
11/02/2000 | EP1048728A1 Means and method for the prevention and or treatment of trypanosomosis |
11/02/2000 | EP1048727A1 Gene encoding novel transmembrane protein |
11/02/2000 | EP1048726A2 Modified factor VIII cDNA |
11/02/2000 | EP1048307A2 Dialysis membrane for the preparation of hematopoietic inhibiting factor containing compositions |
11/02/2000 | EP1047791A1 Use of a proline-rich sequence to improve the fusogenic character of retroviral envelopes |
11/02/2000 | EP1047788A2 Metastatic breast and colon cancer regulated genes |
11/02/2000 | EP1047786A2 Nucleic acid corresponding to mutation associated with cholestasis syndromes |
11/02/2000 | EP1047784A2 Neissera meningitidis antigens |
11/02/2000 | EP1047783A1 Gene associated with disease resistance in plants |
11/02/2000 | EP1047782A1 Interleukin-1 receptor antagonist beta (il-1ra beta) |
11/02/2000 | EP1047781A1 Il-18 receptors |
11/02/2000 | EP1047780A1 Orphan receptors |
11/02/2000 | EP1047779A2 Methods and compositions to alter tissue susceptibility to immune injury, to programmed cell death, and to clearance by the reticuloendothelial system |
11/02/2000 | EP1047778A1 Novel genetic sequences encoding steroid and juvenile hormone receptor polypeptides and insecticidal modalities therefor |
11/02/2000 | EP1047777A2 Novel nucleic acid molecules correlated with the rhesus weak d phenotype |
11/02/2000 | EP1047776A2 Therapeutic composition comprising the kal protein and use of the kal protein |
11/02/2000 | EP1047775A1 Hematopoietic signaling factor |
11/02/2000 | EP1047774A1 Methods and compositions for gene delivery |
11/02/2000 | EP1047773A1 Cubilin protein, dna sequences encoding cubilin and uses thereof |
11/02/2000 | EP1047772A1 Secreted proteins and polynucleotides encoding them |
11/02/2000 | EP1047770A1 Histidine kinase |
11/02/2000 | EP1047714A1 HUMAN CMRF-35-H9 RECEPTOR WHICH BINDS IgM |
11/02/2000 | EP1047713A1 Secreted proteins and polynucleotides encoding them |